Caris Life Sciences, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -71.5% | -103.2% | – | +12.2% | +37.7% | +70.0% | +48.2% | +16.2% | +12.5% | +5.5% | -12.3% | +20.1% | +15.8% | +41.3% | +9.1% | -203.1% | – | – | – | |
| – | +1.2% | -4.4% | -80.7% | +275.1% | +62.8% | +8.0% | +18.3% | +57.7% | +40.8% | +37.5% | +15.2% | +44.9% | -6.6% | +6.2% | +9.0% | -7.7% | -2.9% | -56.4% | +1.6% | -0.2% | -53.8% | |
| – | – | – | – | – | – | -1.3% | +7.8% | +4.7% | +15.1% | +19.3% | +22.7% | +1.6% | -9.6% | +20.5% | +37.4% | -3.8% | -35.6% | +1,190.2% | -33.4% | +22.3% | +275.5% | |
| – | – | – | – | – | +162.5% | -127.8% | – | – | -109.2% | – | – | – | +46.7% | -302.0% | – | – | -176.1% | – | – | – | – | |
| – | +107.1% | -99.7% | +13,000.6% | +379.1% | -7.0% | -84.7% | +559.7% | +137.8% | +6.6% | -40.5% | -1.6% | +26.7% | -35.5% | +99.9% | +61.9% | -60.7% | -31.2% | -80.7% | -47.2% | -62.2% | +92.6% | |
| – | +107.1% | -93.5% | – | -1,158.6% | -6.5% | – | -4,362.7% | +173.6% | +7.2% | -42.2% | -15.5% | +35.5% | -40.5% | +126.7% | +61.1% | -59.0% | -87.5% | +733.1% | – | -75.4% | -130.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +170.8% | +100.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -58.6% | -29.4% | – | – | -16.5% | -76.7% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,791.0% | -86.1% | |
| – | – | – | -98.6% | – | -1.0% | -169.4% | – | +211.3% | +0.0% | -51.9% | -44.7% | +64.5% | -70.2% | +427.1% | +108.6% | -121.2% | +130.4% | – | -3.0% | +1,876.8% | +232.0% | |
| – | – | – | +688.3% | -174.1% | – | -169.9% | – | – | – | +681.2% | -71.2% | -115.7% | – | – | – | -109.5% | – | – | – | – | +9,026.2% | |
| – | – | – | -228.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -669.7% | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.